ArticleDiabetes, obesity & metabolism2025

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial.

David S Mathiesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.